歐普康視(300595.SZ):近日取得2項發明專利證書
格隆匯3月15日丨歐普康視(300595.SZ)公佈,公司於近日收到中華人民共和國國家知識產權局頒發的二項發明專利證書,獲得形式為原始取得,發明名稱為一種用於清潔硬性接觸鏡的護理液及其製備方法、一種凝膠型硬性接觸鏡潤滑液。
上述二項發明專利在於提供快速清潔鏡片的方法和提升鏡片表面親水性的護理方式,有利於保持鏡片的清潔和戴鏡時眼部的濕潤,有益於維持鏡片的光學特性,延長鏡片使用壽命,保持眼部健康和舒適,與以往相關產品相比,具有快速清潔和高效保濕等優勢,可減少鏡片護理時間和維持眼部生態環境。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.